- Home
- Supplements
- CLA (Conjugated Linoleic Acid)
- Cholesterol Management
CLA (Conjugated Linoleic Acid) for Cholesterol Management
CLA does not lower LDL cholesterol. The largest meta-analysis, of 56 trials, found no reliable change in LDL, total cholesterol, triglycerides or apolipoprotein B, and a small fall in HDL. A separate meta-analysis found that use beyond 24 weeks raised lipoprotein(a).
Overview
Verdict
CLA does not lower LDL cholesterol. The largest meta-analysis, of 56 trials, found no reliable change in LDL, total cholesterol, triglycerides or apolipoprotein B, and HDL fell slightly. One CLA isomer worsens cholesterol ratios.
The short answer
CLA (conjugated linoleic acid) is not a cholesterol treatment. The largest meta-analysis, of 56 randomised trials, found that CLA did not reliably change total cholesterol, LDL cholesterol, triglycerides or apolipoprotein B, while HDL cholesterol fell slightly [1]. A second review of 35 trials found total cholesterol fell by just 0.08 mmol/L (about 3 mg/dL) against placebo, while triglycerides rose slightly against olive oil [2], and a 2024 review of people at risk of heart disease found no effect on blood lipids at all [3].
An older 2015 meta-analysis of healthy adults did report a small fall in LDL [4], but the larger and later analyses don't confirm it. NIH's Office of Dietary Supplements sums up the evidence as inconsistent, noting that CLA "might adversely affect lipid profiles" because some isomers may lower HDL and raise lipoprotein(a) [5]. For cholesterol management, CLA is best left out.
Who this page is for
Adults wondering whether CLA, usually sold for weight loss, also helps their cholesterol, or whether it might harm it. If you have high LDL, are on a statin, or have diabetes, the safety section matters most.
At a glance
- Verdict
- No: CLA does not lower LDL cholesterol
- LDL and apolipoprotein B
- No reliable change (56-trial meta-analysis)
- Total cholesterol
- Unchanged, or down about 0.08 mmol/L
- HDL cholesterol
- Slightly lower in several trials
- Triglycerides
- Unchanged, or slightly up vs olive oil
- Lipoprotein(a)
- Raised with use beyond 24 weeks (one meta-analysis)
How It Works
Why CLA was expected to help
CLA is a group of linoleic acid isomers found mainly in dairy products and beef; supplements mostly contain the cis-9,trans-11 and trans-10,cis-12 isomers [5]. It drew interest for cholesterol because animal studies reported antiatherogenic properties [6], and because it may change how the body handles fat: ODS describes proposed effects on fat breakdown, fat-burning in muscle, fat building and fat-cell death [5]. Those proposed effects concern body fat; none of them is a known way of lowering LDL cholesterol.
The two isomers pull in opposite directions
In a crossover trial in healthy men, the two main isomers had opposite effects. The trans-10,cis-12 isomer raised the LDL-to-HDL and total-to-HDL cholesterol ratios and triglycerides compared with the cis-9,trans-11 isomer, which lowered the ratios [6]. In abdominally obese men, purified trans-10,cis-12 CLA lowered HDL cholesterol by 4% against placebo, and the usual isomer mixture lowered it by 2% [7].
The cis-9,trans-11 isomer doesn't rescue the picture either: on its own, as capsules or in enriched milk, it did not improve blood lipids in people with borderline high cholesterol [8][9]. So neither isomer is a route to lower LDL, and animal results don't carry over to the softgels on a shop shelf.
What CLA does to the lipid panel in trials
Dosing & Protocol
Doses tested for lipids
There is no dose that lowers cholesterol, so this page doesn't recommend one. For context, lipid outcomes were measured at about 0.6-2.5 g a day of single isomers [6], 3-3.5 g a day of isomer mixtures [7][8], and up to 6.4 g a day [10]; CLA-enriched milk provided 1.3 g a day [9]. The higher 6.4 g dose lowered HDL cholesterol and raised C-reactive protein [10].
If you already take CLA for weight, know that its effect there is also small (see CLA for weight loss), and recheck your lipids rather than assuming it is helping your cholesterol.
What happened to lipids at each dose
| Who | Dose | Duration | Lipid result |
|---|---|---|---|
| Overweight men with borderline high LDL | 3.5 g/day (mixture or c9,t11) | 8 weeks per phase | No change in blood lipids |
| Overweight adults with borderline high lipids | 1.3 g/day in milk | 8 weeks per phase | No change in LDL, HDL, total cholesterol or triglycerides |
| Abdominally obese men | 3.4 g/day mixture | 12 weeks | HDL down 2% |
| Obese adults | 6.4 g/day | 12 weeks | HDL down; CRP and IL-6 up |
| Children aged 6-10 with overweight or obesity | 3 g/day of 80% CLA | About 7 months | LDL unchanged; HDL down 5.1 vs 0.7 mg/dL with placebo |
From the trials cited on this page. None of these trials showed an LDL fall; the two obese-adult trials did not report LDL.
If you take CLA anyway
- 1
Keep your proven treatment· Always
Don't swap a statin or other prescribed lipid medicine, or a heart-healthy diet, for CLA.
- 2
Get a baseline lipid panel· Before week 1
Total, LDL and HDL cholesterol and triglycerides before you start, plus glucose or HbA1c if you have diabetes risk.
- 3
Recheck after a few months· About week 12
Repeat the panel. Stop if HDL or triglycerides have worsened, or if glucose has risen.
- 4
Stop for liver warning signs· Any time
Stop at once and seek care with jaundice, dark urine or itching; rare hepatitis has been reported with CLA products.
What actually lowers LDL
NHLBI's first steps are limiting saturated fat, eating more whole grains, fruit, vegetables and nuts, regular activity, and losing 3-5% of body weight if you carry extra; statins are the most common medicine. For supplements studied for LDL, see our psyllium and beta-glucan cholesterol pages.
Evidence
The meta-analyses
The broadest review pooled 56 randomised trials (73 effect sizes). Its confidence intervals crossed zero for triglycerides, total cholesterol, LDL cholesterol and apolipoprotein B, meaning no reliable effect, while HDL changed by -0.40 (95% CI -0.72 to -0.07), a small fall [1]. (The paper's own summary misstates these results as rises and an HDL improvement; the confidence intervals are the reliable part.) A 2024 review of 35 trials found total cholesterol 0.08 mmol/L lower than placebo, with very high heterogeneity, and triglycerides 0.05 mmol/L higher than with olive oil [2].
In people at risk of cardiovascular disease, a GRADE-assessed review of 14 trials found "no effect on lipid profile and blood pressure" [3]. The only review to report an LDL fall, from 2015, found a small one in healthy adults [4], and a review of long-term use found that more than 24 weeks of CLA raised lipoprotein(a) and C-reactive protein [11].
Trials in people with raised cholesterol
The trials closest to this page's question are in people who already had raised lipids, and both were null. In 27 overweight men with borderline high LDL, 8 weeks of 3.5 g a day of a CLA mixture or the cis-9,trans-11 isomer did not change blood lipids compared with safflower oil [8]. In overweight adults with borderline high lipids, milk enriched with either natural or synthetic CLA failed to alter total, LDL or HDL cholesterol or triglycerides [9].
Other trials point the same way or worse. In healthy adults, 4.2 g a day for 12 weeks did not change serum lipoproteins [12], and in exercising adults, cholesterol fell in both the CLA and the sunflower-oil groups, so the trial gives no sign of a CLA-specific benefit [13]. A review of CLA added to exercise found no lipid improvement [14], and a year-long safety trial in obese adults found no adverse laboratory changes, lipids included [15].
The HDL problem
Where CLA did move a lipid, it was often HDL, in the wrong direction. HDL fell by 2% with the usual mixture and by 4% with purified trans-10,cis-12 CLA in obese men [7], fell significantly at 6.4 g a day in obese adults [10], and fell by 5.1 mg/dL against 0.7 mg/dL with placebo in children [16].
The exception was 32 people with diet-controlled type 2 diabetes, whose HDL rose by 8% over 8 weeks; in the same trial fasting glucose rose by 6.3% and insulin sensitivity fell, and the authors concluded that a therapeutic nutrient should not carry those adverse effects [17]. See CLA and insulin sensitivity for more on the glucose findings.
Evidence scorecard
- Largest meta-analysis
- 56 trials: no reliable change in LDL, total cholesterol, triglycerides or apoB
- People at cardiovascular risk
- 14 trials: no effect on lipids
- Trials in raised cholesterol
- 2 crossover trials, both null
- HDL cholesterol
- Small fall overall; lower in several trials
- Lipoprotein(a)
- Raised beyond 24 weeks (SMD 0.24)
- Only review with an LDL fall
- 2015, healthy adults, small effect
Trials and reviews that measured CLA's effect on blood lipids, including the null results.
The effects of conjugated linoleic acid supplementation on lipid profile in adults: A systematic review and dose-response meta-analysis
Asbaghi O, Ashtary-Larky D, Naseri K +4 more
In total, 56 RCTs with 73 effect sizes met the inclusion criteria
Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals
Venkatramanan S, Joseph SV, Chouinard PY +3 more
consumption of the two CLA-enriched milks failed to alter plasma total cholesterol
The effect of conjugated linoleic acid supplementation in comparison with omega-6 and omega-9 on lipid profile: a graded, dose-response systematic review and meta-analysis of randomized controlled trials
Akhgarjand C, Tavakoli A, Samavat S +4 more
the meta-analysis considered 35 randomized controlled trials (RCTs) with 1,476 participants
Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis
Liang CW, Cheng HY, Lee YH +3 more
CLA combined with exercise is generally safe
Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men
Joseph SV, Jacques H, Plourde M +3 more
these results do not confirm a role for CLA
Association of foods enriched in conjugated linoleic acid (CLA) and CLA supplements with lipid profile in human studies: a systematic review and meta-analysis
Derakhshande-Rishehri SM, Mansourian M, Kelishadi R +1 more
favourable effects on LDL cholesterol levels
Safety profile of conjugated linoleic acid in a 12-month trial in obese humans
Whigham LD, O'Shea M, Mohede IC +2 more
Laboratory tests showed no adverse effects of CLA
Conjugated linoleic acid supplementation in humans--metabolic effects
Smedman A, Vessby B
No effects on body weight, serum lipids, glucose metabolism, or PAI-1 were seen
Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals
Lambert EV, Goedecke JH, Bluett K +4 more
there were no CLA-specific effects on body composition, energy expenditure or appetite
Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus
Moloney F, Yeow TP, Mullen A +2 more
CLA supplementation had an adverse effect on insulin and glucose metabolism
Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome
Risérus U, Arner P, Brismar K +1 more
t10c12 CLA increased insulin resistance (19%; P < 0.01)
The effects of conjugated linoleic acid supplementation on cardiovascular risk factors in patients at risk of cardiovascular disease: A GRADE-assessed systematic review and dose-response meta-analysis
Esmaeilnejad M, Rasaei N, Goudarzi K +4 more
CLA seems not to have adverse effects on lipid profiles and blood pressure
Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans
Steck SE, Chalecki AM, Miller P +4 more
it may also increase markers of inflammation in the short term
Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans
Tricon S, Burdge GC, Kew S +4 more
trans-10,cis-12 CLA increases LDL:HDL cholesterol and total:HDL cholesterol
Effects of Conjugated Linoleic Acid Intake in the Form of Dietary Supplement or Enriched Food on C-Reactive Protein and Lipoprotein (a) Levels in Humans: A Literature Review and Meta-Analysis
Derakhshandeh-Rishehri SM, Rahbar AR, Ostovar A
The intake of CLA as a dietary supplement led to a significant increase in CRP levels
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans
Gaullier JM, Halse J, Høye K +4 more
reduces BFM in healthy overweight adults
Effect of conjugated linoleic acid on body fat accretion in overweight or obese children
Racine NM, Watras AC, Carrel AL +1 more
decreased HDL more than in the placebo group
Safety
Safety for people watching their cholesterol
CLA appears to be well tolerated; ODS lists mostly digestive complaints such as abdominal discomfort, constipation, diarrhoea, loose stools, nausea and indigestion [5]. For heart health, the concerns are metabolic: lower HDL in several trials [7][10][16], higher lipoprotein(a) and C-reactive protein with long-term use [11], and, with the trans-10,cis-12 isomer, more insulin resistance and higher glucose [5][7]. In people with type 2 diabetes, a 50:50 mixture raised fasting glucose by 6.3% [17].
ODS also notes that CLA might raise markers of oxidative stress and lower breast-milk fat, and that it has been linked to hepatitis in three case reports, although cause was not established because the products were not tested for contaminants [5]. CLA has not been tested in pregnancy for cholesterol, so it is best avoided while pregnant or breastfeeding.
If you have diabetes or low HDL
CLA lowered HDL in several trials and raised glucose and insulin resistance in people with obesity or type 2 diabetes. Those are the wrong direction for heart risk, so talk to your clinician before taking it.
Check with your clinician first if you
Interactions & Conflicts
No formal drug-interaction studies of CLA were found. The practical conflicts come from what trials measured: CLA can lower HDL cholesterol and raise glucose [7][17], and NHLBI notes that statins themselves can slightly raise the risk of diabetes in people already at high risk [18]. Adding CLA does nothing for LDL and could make your results harder to read.
Things to watch (theoretical, not tested)
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Statins, ezetimibe and other cholesterol medicines | low | Theoretical: CLA adds no LDL lowering and may lower HDL | Don't use it as a substitute; tell your prescriber and recheck lipids |
| Diabetes medicines, for example metformin or insulin | low | Theoretical: CLA raised glucose and insulin resistance in some trials | Monitor glucose and talk to your prescriber |
| Medicines or supplements known to affect the liver | low | Theoretical: rare hepatitis case reports with CLA products | Avoid combining; stop with jaundice or dark urine |
References
- Asbaghi O, et al. The effects of conjugated linoleic acid supplementation on lipid profile in adults: A systematic review and dose-response meta-analysis. Front Nutr. 2022;9:953012.DOI: 10.3389/fnut.2022.953012
- Akhgarjand C, et al. The effect of conjugated linoleic acid supplementation in comparison with omega-6 and omega-9 on lipid profile: a graded, dose-response systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2024;11:1336889.DOI: 10.3389/fnut.2024.1336889
- Esmaeilnejad M, et al. The effects of conjugated linoleic acid supplementation on cardiovascular risk factors in patients at risk of cardiovascular disease: A GRADE-assessed systematic review and dose-response meta-analysis. Br J Nutr. 2024;132(7):919-934.DOI: 10.1017/S0007114524001065
- Derakhshande-Rishehri SM, et al. Association of foods enriched in conjugated linoleic acid (CLA) and CLA supplements with lipid profile in human studies: a systematic review and meta-analysis. Public Health Nutr. 2015;18(11):2041-54.DOI: 10.1017/S1368980014002262
- Office of Dietary Supplements, National Institutes of Health. Dietary Supplements for Weight Loss: Fact Sheet for Health Professionals (conjugated linoleic acid section). Updated 18 May 2022. Accessed 24 Oct 2026.
- Tricon S, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr. 2004;80(3):614-20.DOI: 10.1093/ajcn/80.3.614
- Risérus U, et al. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25(9):1516-21.DOI: 10.2337/diacare.25.9.1516
- Joseph SV, et al. Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr. 2011;141(7):1286-91.DOI: 10.3945/jn.110.135087
- Venkatramanan S, et al. Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr. 2010;29(2):152-9.DOI: 10.1080/07315724.2010.10719829
- Steck SE, et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr. 2007;137(5):1188-93.DOI: 10.1093/jn/137.5.1188
- Derakhshandeh-Rishehri SM, et al. Effects of Conjugated Linoleic Acid Intake in the Form of Dietary Supplement or Enriched Food on C-Reactive Protein and Lipoprotein (a) Levels in Humans: A Literature Review and Meta-Analysis. Iran J Med Sci. 2019;44(5):359-373.DOI: 10.30476/IJMS.2019.44949
- Smedman A, et al. Conjugated linoleic acid supplementation in humans--metabolic effects. Lipids. 2001;36(8):773-81.DOI: 10.1007/s11745-001-0784-7
- Lambert EV, et al. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br J Nutr. 2007;97(5):1001-11.DOI: 10.1017/S0007114507172822
- Liang CW, et al. Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis. Nutr Rev. 2023;81(4):397-415.DOI: 10.1093/nutrit/nuac060
- Whigham LD, et al. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol. 2004;42(10):1701-9.DOI: 10.1016/j.fct.2004.06.008
- Racine NM, et al. Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr. 2010;91(5):1157-64.DOI: 10.3945/ajcn.2009.28404
- Moloney F, et al. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80(4):887-95.DOI: 10.1093/ajcn/80.4.887
- National Heart, Lung, and Blood Institute. Blood Cholesterol: Treatment. Last updated 19 Apr 2024. Accessed 24 Oct 2026.
Frequently Asked Questions
Does CLA lower cholesterol?
Does CLA lower LDL cholesterol?
Does CLA raise HDL cholesterol?
Does CLA raise triglycerides or lipoprotein(a)?
Can I take CLA with a statin?
Is CLA from milk, butter or beef better for cholesterol?
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.